Hypera SA (BSP:HYPE3)
R$ 20.95 -0.57 (-2.65%) Market Cap: 13.25 Bil Enterprise Value: 20.62 Bil PE Ratio: 7.90 PB Ratio: 1.11 GF Score: 88/100

Q1 2021 Hypera SA Earnings Call Transcript

Apr 26, 2021 / 02:00PM GMT
Release Date Price: R$35.02 (-1.85%)
Operator

Good morning. Welcome to Hypera Pharma First Quarter 2021 Results Earnings Call. Mr. Breno Oliveira, CEO; and Mr. Adalmario Couto, CFO and IRO, are here with us today. This event is being recorded. (Operator Instructions) Today's live webcast is being broadcast at www.hypera.com.br/ir.

We also would like to inform that statements during this conference may continue forward-looking statements. Such statements are subject to known and unknown risks and uncertainties that could cause the company's actual results to differ materially from those expected.

I'll turn the floor over to Mr. Breno Oliveira. Mr. Oliveira, you have the floor.

Breno Toledo Pires de Oliveira
Hypera S.A. - CEO

Good morning, everyone. Welcome to our first quarter earnings call. I would like to start by talking about our growth on Slide 3. For the second quarter in a row, we grew our sell-out organically in double digits and we gained market share. Organic growth was 11.5% in our sell-out, 2 percentage

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot